Is PTHS or PYPD more undervalued in 2026?

CirclFi compares Pelthos Therapeutics Inc. (PTHS) and PolyPid Ltd. (PYPD) using 13 institutional-grade valuation models. PTHS has a Quality of Company score of 4.4/10 while PYPD scores 1.8/10.

Which is a better buy — PTHS or PYPD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PTHS and PYPD valuations compare?

PTHS at $25.80 and PYPD at $4.76 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PTHS vs PYPD Valuation Comparison 2026 — Intrinsic Value Analysis

PTHS

Biotechnology

Pelthos Therapeutics Inc.

Quality

4.4

out of 10

Value Trap

LOW

Price

$25.80

Last close

Models

10/13

Active

PYPD

Biotechnology

PolyPid Ltd.

Quality

1.8

out of 10

Value Trap

—

Price

$4.76

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	PTHS Fair Value	PTHS Upside	PYPD Fair Value	PYPD Upside
Bayesian DCF	Intrinsic	$9.58	-62.9%	$1.26	-73.5%
Earnings Power Value	Intrinsic	$16.77	-32.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$14.53	-43.7%	$26.22	+450.9%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PTHS vs PYPD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PTHS vs PYPD — Which Stock Is More Undervalued?

PTHS scores higher with a 4.4/10 quality rating vs PYPD's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Pelthos Therapeutics Inc. (PTHS) and PolyPid Ltd. (PYPD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PTHS currently trades at $25.80 with a QOC of 4.4/10, while PYPD trades at $4.76 with a QOC of 1.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).